Morphine is the analyte that most standard opiate drug test panels are actually built to catch. It is the primary target of the immunoassay screen labeled OPI or opiates, and it shows up on a urine test because morphine itself is a controlled substance and because it is also the metabolite the body produces when it breaks down codeine and heroin. Understanding how the screen works, what cutoff level counts as positive, and how a laboratory and a medical review officer sort out where the morphine came from helps employers and donors read a result correctly instead of guessing.
What the opiate panel is actually screening for
Under the federal framework used for regulated workplace testing, the opiate class historically covered the "NIDA five" screen alongside amphetamines, cannabinoids, cocaine, and phencyclidine. Opiates in the strict sense are natural compounds derived from the opium poppy, including morphine, codeine, and heroin (chemically diacetylmorphine). Opioids is the broader term that also covers synthetic and semisynthetic drugs such as oxycodone, hydrocodone, methadone, and fentanyl, some of which require a separate expanded panel to detect. A standard OPI immunoassay is designed to react to morphine and codeine and their close relatives, which is why a positive opiate screen so often comes back to morphine specifically, according to the National Institutes of Health StatPearls overview of opioid toxicity. Morphine itself is a Schedule II controlled substance under federal law, reflecting an accepted medical use alongside a recognized potential for abuse, as listed in 21 CFR 1308.12, the DEA schedule of controlled substances.
Federal cutoff levels for morphine and codeine
Federally regulated testing, including U.S. Department of Transportation programs, follows cutoff concentrations set out in 49 CFR Part 40 and mirrored in the HHS Mandatory Guidelines for federal workplace drug testing programs, administered through SAMHSA. The initial immunoassay screen and the confirmatory test use different, more specific cutoffs for each analyte.
| Analyte | Initial (immunoassay) screening cutoff | Confirmatory test cutoff |
|---|---|---|
| Codeine / Morphine (combined screen) | 2000 ng/mL | Codeine 2000 ng/mL; Morphine 2000 ng/mL |
| 6-Acetylmorphine (6-AM) | 10 ng/mL | 10 ng/mL |
Those numbers are set out directly in 49 CFR 40.85, the section of the DOT drug testing rule that lists cutoff concentrations for urine drug tests. A urine specimen has to reach 2000 nanograms per milliliter of morphine or codeine on the initial screen before a laboratory even runs a confirmatory test, and it has to confirm at that same level on the more specific method. That is a comparatively high bar next to some other drug classes, and the reason for it is explained further below.
Why a positive morphine result does not prove heroin use
Heroin breaks down in the body very quickly into 6-acetylmorphine, then further into morphine. 6-AM is the only metabolite that is unique to heroin. Morphine itself is not, because morphine is also a medication in its own right (morphine sulfate, extended release products such as MS Contin, and injectable morphine used in medical settings), and it is also the downstream metabolite of codeine. That means a urine specimen that is positive for morphine but negative for 6-AM cannot, on its own, distinguish recent heroin use from codeine use, a legitimate morphine prescription, or in some cases dietary poppy seed exposure. Laboratories that run a confirmatory test for 6-AM alongside morphine and codeine are the ones equipped to make that distinction. For a closer look at how 6-AM confirmation works, see our related post on what 6-acetylmorphine means for heroin confirmation.
The poppy seed problem and why the cutoff was raised
Poppy seeds used in food products can carry trace amounts of morphine and codeine from the seed coat, and eating a large quantity close to a scheduled test has been documented to push a urine result above older, lower cutoffs. That history is part of why the federal cutoff sits at 2000 ng/mL rather than a lower threshold used in earlier versions of the guidelines. Under 49 CFR 40.139, the DOT rule governing how a medical review officer evaluates confirmed opiate positives, a laboratory-confirmed presence of 6-AM must be verified positive outright. In the absence of 6-AM, if morphine or codeine reaches 15,000 ng/mL in urine, the rule specifically states that consumption of food products such as poppy seeds cannot be treated as a legitimate medical explanation at that concentration. For results below that higher threshold, the medical review officer must find actual clinical evidence of unauthorized opiate use before verifying a positive, not the lab result alone. We cover the food science side of this in more depth in our post on the science behind poppy seed opiate false positives.
How a positive screen gets confirmed
An immunoassay is a fast, inexpensive screening tool, but it is not specific enough on its own to report a legally or employment defensible positive. Federal programs and most workplace policies require a presumptive positive screen to be confirmed with a more specific analytical method, typically gas chromatography mass spectrometry (GC/MS) or liquid chromatography tandem mass spectrometry (LC-MS/MS). These methods separate and quantify codeine, morphine, and 6-AM individually rather than reporting a single combined opiate result, which is what allows the cutoff distinctions above to function. The NIH StatPearls chapter on drug testing describes this two-step screen-then-confirm structure as standard practice across clinical and workplace toxicology.
The medical review officer process and prescription documentation
In DOT-regulated and most other well-run testing programs, a laboratory does not report a confirmed positive straight to an employer. A qualified medical review officer reviews the result first and gives the donor an opportunity to provide a legitimate medical explanation, which most often means a current prescription verified against pharmacy or prescriber records. Someone taking a prescribed morphine product for pain management, or a codeine-containing prescription that legitimately metabolizes into morphine, generally has that explanation documented and the medical review officer factors it into the verification decision under the same 49 CFR Part 40 framework referenced above. Employers should treat this as a compliance and documentation process handled by the medical review officer rather than something to resolve informally at the worksite, and safety sensitive fitness for duty questions are a separate matter from the drug test result itself.
What counts as a positive, in plain terms
Putting the pieces together: morphine shows up on a standard opiate drug test because it is both a directly detectable substance and the shared downstream metabolite of codeine and heroin. Whether that morphine reading becomes a reportable positive depends on the screening cutoff being met, confirmation by GC/MS or LC-MS/MS, whether 6-AM is also present, and the medical review officer's evaluation of any legitimate medical explanation. Detection windows for morphine in urine vary with dose, frequency of use, individual metabolism, hydration, and the specific cutoff a laboratory applies, so no single fixed number of days applies to every person or every test, and no testing provider can promise an exact clearance date.
Frequently asked questions
Does morphine show up on a standard workplace opiate drug test?
Yes. Morphine is the primary target of the opiate (OPI) immunoassay used in most urine drug test panels, and it also appears as a metabolite of codeine and heroin.
Can eating poppy seeds cause a positive morphine result?
Poppy seeds can contain trace morphine and codeine, and this has been documented to affect urine results near older, lower cutoffs. The federal cutoff was set at 2000 ng/mL in part to reduce this issue, and 49 CFR 40.139 sets a further threshold and clinical evidence standard the medical review officer applies before verifying a positive.
Does a positive morphine result mean the person used heroin?
Not by itself. Morphine is also a legitimate medication and a metabolite of codeine. Only the presence of 6-acetylmorphine (6-AM), a metabolite unique to heroin, points specifically to heroin use, and 6-AM has a separate, lower confirmatory cutoff of 10 ng/mL.
What happens if someone has a valid prescription for morphine?
The medical review officer reviews confirmed positive results and gives the donor a chance to provide documentation such as a current, verifiable prescription. This review happens under the medical review officer process described in 49 CFR Part 40 rather than being decided by the employer directly.
How is a positive opiate screen confirmed in the lab?
Laboratories confirm a presumptive positive immunoassay with a more specific method, typically gas chromatography mass spectrometry (GC/MS) or liquid chromatography tandem mass spectrometry (LC-MS/MS), which separately identifies and quantifies codeine, morphine, and 6-AM.
What federal cutoff level applies to morphine in a DOT regulated test?
Under 49 CFR 40.85, the combined codeine and morphine initial screening cutoff is 2000 ng/mL, with a confirmatory cutoff of 2000 ng/mL for morphine and 2000 ng/mL for codeine individually.
American Screening Corporation supplies opiate immunoassay cups, dip cards, and oral fluid tests used across workplace and clinical testing programs, along with laboratory confirmation services. Browse our drug test cup collection for panels that include the opiate (OPI) screen.
This article is general information about drug testing science and federal regulations, not legal or medical advice. Employers should consult qualified counsel and a medical review officer for guidance specific to a testing program, and individuals with questions about a medication or a test result should speak with a licensed healthcare provider.
